The influence of chloroquine-dosage as comedication on the response of non-responder dialysispatients at Hepatitis B vaccine

• Conditions: immunodeficiency; renal disease; 10021460; 10029149

• Registration Number: NL-OMON29902
• Lead Sponsor: Máxima Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Chronic hemodialysis patients,
Terminated Hepatitis B vaccination programme
Anti HbAl-titier < 10 IU/l

Exclusion Criteria

Myasthenia Gravis,
Rethinopathia,
Hypersensitivity of 4-aminochinolinederivates

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Titre HbsAl in both arms</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>